MedPath

Trans-obturator Mid-urethral Sling and the Single-incision Sling in Women With Stress Urinary Incontinence

Not Applicable
Completed
Conditions
Urinary Incontinence, Stress
Interventions
Device: TOT - inside-out trans-obturator tape/sling
Device: SIS - Innovative fixation single incision sling
Registration Number
NCT02506309
Lead Sponsor
Brno University Hospital
Brief Summary

Mid-urethral slings (MUS) now represent a gold standard in the treatment of female stress urinary incontinence (SUI). Second generation trans-obturator slings (TOT) have proven to be as effective as retropubic tension-free vaginal tape (TVT) with fewer major complications. A third generation of the MUS inserted through a single vaginal incision (SIS) has become a means to overcome significant post-operative groin pain. Novel types of SIS with a more robust and adjustable anchoring mechanism can assure adequate long-lasting attachment to the obturator membrane (OM). Objective of this study was to compare an inside-out TOT with an innovative fixation SIS in randomized controlled trial on patients undergoing their primary surgery for urodynamic SUI.

Detailed Description

Objective of this study was to compare an inside-out TOT (Gynecare TVT Obturator System, Ethicon) with an innovative fixation SIS (Ophira, Promedon) in randomized controlled trial on patients undergoing their primary surgery for urodynamic SUI.

A prospective randomized controlled trial (RCT) is performed in one tertiary referral urogynecology center from January 2015 thru December 2015. Study included women with pure or predominant urodynamic SUI confirmed during cystometry by positive standardized cough stress test (CST) with urinary bladder filling of 250 ml in lithotomy position. Study was carried out on a Caucasian Czech (central European) population. A study power analysis was calculated with an expected objective cure rate of minimum 80 % for both patient groups, false non-match rate (alpha) of 0.05, and false match rate (beta) of 0.10. A minimum sample size of 80 patients was required for each group.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
168
Inclusion Criteria

Women with pure or predominant urodynamic stress urinary incontinence confirmed during filling cystometry by positive standardized cough stress test (CST) with urinary bladder filling of 250 ml in lithotomy position.

Exclusion Criteria
  • patients with predominant urge incontinence
  • patients with intrinsic sphincter deficiency (MUCP<20 cmH2O)
  • pelvic organ prolapse (POP-Q>2)
  • previous urinary incontinence surgery
  • previous pelvic organ prolapse surgery
  • presence of other pelvic organ pathology.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TOT trans obturator tape/slingTOT - inside-out trans-obturator tape/slingTOT - inside-out trans-obturator tape/sling Trans-obturator slings (TOT) now represent a gold standard in the treatment of female stress urinary incontinence (SUI).
SIS single incision slingSIS - Innovative fixation single incision slingSIS - Innovative fixation single incision sling A third generation of the Mid-urethral slings inserted through a SIS single incision sling (SIS) to treat female stress urinary incontinence (SUI).
Primary Outcome Measures
NameTimeMethod
Patient Global Impression of Improvement (PGI-I) Scorefour years

Patient Global Impression of Improvement (PGI-I) score four years after incontinence surgery. The Patient Global Impression of Improvement (PGI-I) is a global index that may be used to rate the response of a condition to a therapy (transition scale). It is a simple, direct, easy to use scale that is intuitively understandable to clinicians

1. Very much better

2. Much better

3. A little better

4. No change

5. A little worse

6. Much worse

7. Very much worse

Percentage of Participants With Negative Cough Stress Test (CST)four years

Negative cough stress test four years after incontinence surgery.

Secondary Outcome Measures
NameTimeMethod
Number of Participants With Major Postoperative Complicationsfour years
Number of Participants With Major Perioperative Complicationsone month
© Copyright 2025. All Rights Reserved by MedPath